Literature DB >> 18052717

Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury?

Matthew Whiteman1, Jeremy P E Spencer, Hazel H Szeto, Jeffrey S Armstrong.   

Abstract

Reactive chlorine species such as hypochlorous acid (HOCl) are cytotoxic oxidants generated by activated neutrophils at the sites of chronic inflammation. Since mitochondria are key mediators of apoptosis and necrosis, we hypothesized that mitochondriotropic antioxidants could limit HOCl-mediated intracellular oxidative injury to human fetal liver cells, preserve mitochondrial function, and prevent cell death. In this current study, we show that recently developed mitochondria-targeted antioxidants (MitoQ and SS31) significantly protected against HOCl-induced mitochondrial damage and cell death at concentrations >or=25 nM. Our study highlights the potential application of mitochondria-specific targeted antioxidants for the prevention of cellular dysfunction and cell death under conditions of chlorinative stress, as occurs during chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18052717     DOI: 10.1089/ars.2007.1879

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  15 in total

1.  SS31 therapy effectively protects the heart against transverse aortic constriction-induced hypertrophic cardiomyopathy damage.

Authors:  Hung-I Lu; Fan-Yen Lee; Christopher Glenn Wallace; Pei-Hsun Sung; Kuan-Hung Chen; Jiunn-Jye Sheu; Sarah Chua; Meng-Shen Tong; Tien-Hung Huang; Yi-Ling Chen; Pei-Lin Shao; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Authors:  Atefeh Jafari; Hossein Khalili; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2014-06-25       Impact factor: 2.953

3.  Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.

Authors:  Dao-Fu Dai; Tony Chen; Hazel Szeto; Madeline Nieves-Cintrón; Vassily Kutyavin; Luis F Santana; Peter S Rabinovitch
Journal:  J Am Coll Cardiol       Date:  2011-05-27       Impact factor: 24.094

Review 4.  Novel therapies targeting inner mitochondrial membrane--from discovery to clinical development.

Authors:  Hazel H Szeto; Peter W Schiller
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 5.  Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.

Authors:  Nadezda Apostolova; Victor M Victor
Journal:  Antioxid Redox Signal       Date:  2015-03-10       Impact factor: 8.401

Review 6.  Mitochondrial oxidative stress and mammalian healthspan.

Authors:  Jonathan Wanagat; Dao-Fu Dai; Peter Rabinovitch
Journal:  Mech Ageing Dev       Date:  2010-06-08       Impact factor: 5.432

Review 7.  Cardiac aging: from molecular mechanisms to significance in human health and disease.

Authors:  Dao-Fu Dai; Tony Chen; Simon C Johnson; Hazel Szeto; Peter S Rabinovitch
Journal:  Antioxid Redox Signal       Date:  2012-04-03       Impact factor: 8.401

8.  Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice.

Authors:  Hung-I Lu; Tien-Hung Huang; Pei-Hsun Sung; Yung-Lung Chen; Sarah Chua; Han-Yan Chai; Sheng-Ying Chung; Chu-Feng Liu; Cheuk-Kwan Sun; Hsueh-Wen Chang; Yen-Yi Zhen; Fan-Yen Lee; Hon-Kan Yip
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

9.  Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Authors:  Lichuan Yang; Kesheng Zhao; Noel Y Calingasan; Guoxiong Luo; Hazel H Szeto; M Flint Beal
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

10.  Carnosic Acid Protects Mitochondria of Human Neuroblastoma SH-SY5Y Cells Exposed to Paraquat Through Activation of the Nrf2/HO-1Axis.

Authors:  Marcos Roberto de Oliveira; Alessandra Peres; Gustavo Costa Ferreira; Patrícia Fernanda Schuck; Clarissa S Gama; Simone Morelo Dal Bosco
Journal:  Mol Neurobiol       Date:  2016-09-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.